0001639691-21-000075.txt : 20210701 0001639691-21-000075.hdr.sgml : 20210701 20210701185708 ACCESSION NUMBER: 0001639691-21-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210629 FILED AS OF DATE: 20210701 DATE AS OF CHANGE: 20210701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRISON HUGH M CENTRAL INDEX KEY: 0001194337 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37599 FILM NUMBER: 211067512 MAIL ADDRESS: STREET 1: 2517 BLUEBONNET CITY: HOUSTON STATE: TX ZIP: 77030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LivaNova PLC CENTRAL INDEX KEY: 0001639691 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 981268150 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 EASTBOURNE TERRACE CITY: LONDON STATE: X0 ZIP: W2 6LG BUSINESS PHONE: 4402033250662 MAIL ADDRESS: STREET 1: 20 EASTBOURNE TERRACE CITY: LONDON STATE: X0 ZIP: W2 6LG FORMER COMPANY: FORMER CONFORMED NAME: Sand Holdco Plc DATE OF NAME CHANGE: 20150420 FORMER COMPANY: FORMER CONFORMED NAME: Sand Holdco Ltd DATE OF NAME CHANGE: 20150415 4 1 wf-form4_162518019311683.xml FORM 4 X0306 4 2021-06-29 1 0001639691 LivaNova PLC LIVN 0001194337 MORRISON HUGH M 20 EASTBOURNE TERRACE LONDON X0 W2 6LG UNITED KINGDOM 1 0 0 0 Ordinary Shares 2021-06-29 4 M 0 2337 0 A 5266 D Restricted Stock Units 2021-06-29 4 M 0 2337 0 D Ordinary Shares 2337.0 0 D Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value. Each RSU represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the Plan) and the award agreement. On June 29, 2020, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 29, 2021, subject to continued service during the vesting period and the RSU Agreement. This number reflects the number of derivative securities beneficially owned following reported transaction for this specific grant. /s/ Sarah K. Mohr, POA 2021-07-01